Our Team
Our vision is to transform the Life Sciences industry with technology-enabled solutions, Quality Compliance and Consulting services.
We are passionate about our work and get inspiration from the challenges – we love taking on complex projects that give us an opportunity to innovate.
It gives us great satisfaction to know that we owe our success to the talents of our Team, and to the exceptional engagement we have with our Clients and Partners.
Our Executive Team
Paolo Morelli
CEO
Paolo is a passionate entrepreneur who has over 24 years of experience in the Life Sciences industry.
He is involved as a scientific advisor in multiple technology innovation start-ups and contributed to a number of leading industry associations.
Paolo’s goal is to continue investing in new technologies such as Artificial Intelligence, Machine Learning, Internet of Things and digital health.
He is committed to contributing to the transformation of clinical trials through technology to support the delivery of treatments to patients faster, safer, and smarter.
Giorgio Jones
CFO & HR Director
Giorgio brings nearly 30 years of experience in the pharmaceutical industry to this role with over 25 years spent in the CRO sector, covering key roles in Finance and HR.
Giorgio qualified in 1998 as a Chartered Management Accountant and is a Chartered Member of the Institute of Personnel and Development.
He has served on a number of SME Boards during the last 20 years.
Sergio Scaccabarozzi
Scientific Director
With a medical degree and a specialization in general surgery from Università degli Studi in Milan, Sergio Scaccabarozzi has 35 years of experience in Clinical Research for global pharmaceutical and biotechnology companies.
In his professional life, Sergio spent 12 years as Head of Clinical Operations for the Italian affiliate of a big pharma and biotechnology company, managing a team of 90+ people and more than 220 studies from Phase I to Phase IV, RWE and providing support to institutions for Investigator initiated studies.
Sergio Scaccabarozzi enriched his professional experience by spending one year and a half as Operation Research Manager in one of the most important public research hospitals in Italy.
Sergio Scaccabarozzi is a member of scientific societies and working groups on Clinical Research, a recognized speaker at national and international events, with active editorial activities on Clinical Research and Life Science in general.
Silvia Gabanti
Managing Director of the Technology Business Unit
Silvia Gabanti has an impressive 18-year track record in the industry. She began her career in the CRO environment as pharmacovigilance and clinical research specialist. Experienced project manager and business analyst, for the last three years before becoming Managing Director of Arithmos, she held the position of Head of Life Sciences.
A frequent speaker at the national and international industry events, Silvia is passionate about reorganising and streamlining processes and implementing reliable and cost-effective solutions to improve quality, enhance departments efficiencies and increase customer satisfaction.
Antonella Ursini
Managing Director of the Regulatory Business Unit
Antonella has over 25 years of experience in Pharmaceutical R&D with leadership and management experience of global, multi-disciplinary teams, across all phases of drug development.
She has a background in organic and pharmaceutical chemistry and technology.
After graduation, she joined GLAXO and worked on synthesis of new molecules. She moved then to Preclinical Development, at GW then GSK, with responsibility for Business and Projects Operations, including Quality and Operational Excellence.
Prior to starting with seQure in 2017, she held positions at Aptuit as Head of Quality and Compliance, ensuring compliant GLP and GMP Quality Systems for Verona and Oxford.
Stefania De Santis
Director of Pharmacovigilance of the Regulatory Business Unit
Stefania De Santis is a qualified EU QPPV and is seQure’s Director of Pharmacovigilance; as such she is responsible for strategic planning and workflow development as well as guaranteeing the quality of our pharmacovigilance services.
Stefania has more than 30 years of experience in the pharmaceutical sector where she has been involved in various departments, but mainly in Pharmacovigilance, throughout her career. Before joining seQure, she was dedicated to the field of pharmacovigilance as Head of Corporate Drug Safety and qualified Deputy EU QPPV for a major pharmaceutical company since 1992.
Stefania has extensive experience in all pharmacovigilance operations, in both pre-registration and post-marketing settings, case processing, PSUR and DSUR preparation, ICSR/SUSAR management and electronic transmission to the EMA, signal detection and management, safety database validation, safety variations, RMPs development, SDEA/Safety Management Plans and liaising with regulatory authorities.
She is certified by the EMA for the use of Eudravigilance and EXVMPD (Medicinal Product Dictionary).
Maurizio Giraudo
Managing Director of the Consulting Business Unit
With a law degree from La Sapienza University in Rome, Maurizio Giraudo is a management consulting professional with over 20 years of experience in Life Sciences from commercial excellence and digital transformation to R&D, regulatory affairs and manufacturing for global pharmaceutical, biotechnology, and medical device companies.
His career also boasts consulting experience with Accenture and EY, with a combined 14 years as a senior consultant and manager in the Life Sciences divisions.
Ewan Campbell
Managing Director of The CQA Company, an Arithmos company
Ewan is a serial entrepreneur with over 30 years of experience in the Health Care industry covering all aspects of the product life-cycle including Pre-clinical, Clinical, Regulatory, Quality and Post-marketing. He specializes in the development of products which do not have a classical regulatory route to market.
Ewan began his career in the UK NHS in Haematology before moving into Manufacturing and Quality Control. His first Biotech, which was sold to Abbott in Chicago, developed one of the first device/drug combination products to be approved and the technology is still used on the endeavourTM stent. Ewan’s second Biotech was an advanced therapy company and he was subsequently involved in the first gene therapy to get approval in the European Union. Ewan was also a non-Executive director of a Pre-clinical laboratory which was sold to Charles River Laboratories.
After being involved in two successful biotech start-up companies, Ewan set up The Clinical Trial Company which was sold to a US CRO in 2019. Ewan also set up The CQA company, which was acquired by Arithmos in 2022, to provide GxP consultancy, assisting companies in bringing their innovative products to market in a compliant and timely way.
Ewan is a Qualified Person (QP) in the EU and UK and routinely certifies IMPs.